Intraarterial route increases the risk of cerebral lesions after mesenchymal cell administration in animal model of ischemia

Mesenchymal stem cells (MSCs) are a promising clinical therapy for ischemic stroke. However, critical parameters, such as the most effective administration route, remain unclear. Intravenous (i.v.) and intraarterial (i.a.) delivery routes have yielded varied outcomes across studies, potentially due...

Descripción completa

Detalles Bibliográficos
Autores principales: Argibay, Bárbara, Trekker, Jesse, Himmelreich, Uwe, Beiras, Andrés, Topete, Antonio, Taboada, Pablo, Pérez-Mato, María, Vieites-Prado, Alba, Iglesias-Rey, Ramón, Rivas, José, Planas, Anna M., Sobrino, Tomás, Castillo, José, Campos, Francisco
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2017
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5238501/
https://www.ncbi.nlm.nih.gov/pubmed/28091591
http://dx.doi.org/10.1038/srep40758

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5238501/
https://www.ncbi.nlm.nih.gov/pubmed/28091591
http://dx.doi.org/10.1038/srep40758

Ejemplares similares